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Introduction: Pancreatic cancer is the fourth cause of death from cancer in Western countries. The radical
surgical resection is the only curative option for this pathology. The prevalence of this disease increases
with age in population. The causes of pancreatic cancer are unknown, but we consider risk factors like
smoke and tobacco usage, alcohol consumption coffee, history of diabetes or chronic pancreatitis. In this
study we report our experience in the treatment of resectable pancreatic cancer and periampullary
neoplasms with particular attention to evaluate the evolution of surgical technique and the clinical
postoperative outcomes.
Methods: In our Department between January 2010 and December 2014 we performed a total of 97
pancreaticoduodenectomy. We considered only resectable pancreatic cancer and periampullary neo-
plasms deﬁned by absence of distant metastases, absence of local tumor extension to the celiac axis and
hepatic artery as the lack of involvement of the superior mesenteric vasculature. None of these patients
received neoadjuvant chemotherapy.
Results: The mean age of these patients was 64.5 years. Jaundice was the commonest presenting
symptom associated to anorexia and weight loss. The mean operative time was 295 min (±55 min). The
mean blood loss was 450 ml and median blood transfusion was 1 units. 12.1% of patients had an intra-
abdominal complication. The commonest complication was Delayed Gastric Emptying responsable of
increased length of hospital stay and readmission rate. Postoperative pancreatic ﬁstula of grade C
occurred in 4 patients. 2 patients developed a postpancreatectomy hemorrhage. Perioperative mortality
was 4.1%.
Conclusion: Pancreaticoduodenectomy is a complex surgical technique and the associated high
morbidity and mortality resulted in initial reluctance to adopt this surgery for the management of
pancreatic and periampullary tumors. Surgical outcomes of pancreatic surgery are better at high-volume
experienced center reporting mortality rates below 5%. We perform an end-to-side duct-to-mucosa
pancreaticojejunostomy with routinely use of internal pancreatic stent. However no one technique has
been shown to deﬁnitely be the solution to the problem of postoperative pancreatic ﬁstula. At our center
we have a reasonable volume and our data are comparable to literature data.
© 2015 IJS Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.Romano), antonino.agrusa@
a), g.dibuono@libero.it (G. Di
zosorce@me.com (V. Sorce),
.gulotta@unipa.it (G. Gulotta).
ished by Elsevier Ltd. All rights res1. Introduction
Pancreatic cancer is one of the most important neoplasm in
Western countries and it is the fourth cause of death from cancer
[1]. The radical surgical resection is the only curative option, but
unfortunately more than 80% of patients presents unresectable
disease to hospital access. Riall TS et al. showed that the 5-yearerved.
Table 1
Characteristic of patients underwent to pancreaticoduodenectomy.
Variables Values (n ¼ 97)
Age 64.5 (range 33e83) years
Sex (%)
Males 53 (54.6)
Females 44 (45.4)
Symptoms (%)
Jaundice 89 (92)
Anorexia/weight loss 72 (74)
Abdominal pain 55 (57)
Nausea and vomiting 38 (39)
ASA score
1e2 9
3e4 88
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15e20% [2]. We know that this survival is higher for the others
periampullary neoplasms like distal bile duct cancer (20e25%),
ampullary cancer (30e40%) and duodenal cancer (50e60%). For the
same reason in the past decades many surgeons recommended
only palliative care for patients with periampullary cancers [3,4].
The prevalence of this disease increases with age in population.
Patients 20e29 years old have an annual incidence of 0.1 cases of
pancreatic cancer per 100,000 population, while patients older
than 80 have an annual incidence of 87.2 cases per 100,000 pop-
ulation. The causes of pancreatic cancer are unknown, but we
consider risk factors like smoke and tobacco usage, alcohol com-
sumption, coffee, history of diabetes or chronic pancreatitis [5]. In
this study we report our experience in the treatment of resectable
pancreatic cancer and periampullary neoplasms with particular
attention to evaluate the evolution of surgical technique and the
clinical postoperative outcomes.
2. Methods
In our Department of General and Emergency Surgery at the
University Hospital Policlinico “P. Giaccone” of Palermo between
January 2010 and December 2014 we performed a total of 97
pancreaticoduodenectomy. In this retrospective study the patient
characteristics registered were age, gender, presenting symptoms,
past medical history and presence of comorbidity with American
Society of Anesthesiology (ASA) score, operative time, post-
operative complication including causes of re-laparotomy and
death [6,7]. We considered only resectable pancreatic cancer and
periampullary neoplasms deﬁned by absence of distant metastases,
absence of local tumor extension to the celiac axis and hepatic ar-
tery as the lack of involvement of the superior mesenteric vascu-
lature. None of these patients received neoadjuvant chemotherapy
[8].
2.1. Pre-operative wok up
Before surgery all patients were submitted routinely to
computed tomography (CT) scan to study the characteristics and
size of the lesion. Abdominal magnetic resonance imaging (MRI)
and endo-ultrasonography were performed for selected patients
[9,10]. Pre-operative biliary drainage was done with ERCP if the
serum bilirubin was more than 20 mg/dl or if the patient had fever
because of acute cholangitis [11,12].
2.2. Surgical technique
All patients were explored using a bilateral subcostal laparot-
omy. All patients underwent a standard Whipple pan-
creaticoduodenectomy. For pancreaticojejunostomy we used an
end-to-side duct-to-mucosa anastomosis. In this case a two-layer
anastomosis was constructed with interrupted absorbable suture
material, beginning with a posterior row of seromuscular sutures
securing the jejunum to the pancreas. The pancreatic duct-to-
mucosa anastomosis was performed to an enterotomy in the
jejunumwith a second circumferential layer of interrupted sutures,
followed by completion of an anterior layer of seromuscular sutures
between anterior aspect of jejunum and pancreatic capsule. In
other cases we used a modiﬁed duct-to-mucosa technique, origi-
nally created by Blumgart [13]. In this technique an outer layer of
absorbable sutures are ﬁrst inserted full-thickness anterior-to-
posterior through the pancreas with subsequent seromuscular
stitches on the jejunum. In both cases we used an internal
pancreatic duct stent (size 4e5 Fr) in order to divert the pancreatic
secretions away from the pancreaticojejunal anastomosis withdecreased risk for leak formation [14]. Than we performed end-to-
side hepaticojejunostomy and ﬁnally gastrojejunostomy.2.3. Post-operative analysis
We considered the morbidity like complication that requiring
medical or surgical intervention. Causes of morbidity, related to
surgical technique, were postoperative pancreatic ﬁstula (POPF),
delayed gastric emptying (DGE) and postpancreatectomy hemor-
rhage with bleeding in the form of fresh blood in nasogastric tube
or hematemesis and/or melena necessitating of blood transfusion,
embolization or relaparotomy [15e18]. Perioperative mortality was
all deaths within 30 days of surgery or in the same admission,
irrespective of cause.3. Results
During the study period we treated 97 patients with Whipple
procedure, 53 males and 44 females.
Preoperative data: themean age of these patients was 64.5 years
(range 33e83). Jaundice was the commonest presenting symptom
associated to anorexia and weight loss; fewer patients had
abdominal pain, nausea and vomiting (Table 1). Only 8 patients
(7.8%) underwent a preoperative biliary drainage with ERCP, pap-
illotomy and temporary stent. We also registered the presence of
comorbidity with American Society of Anesthesiology (ASA) score.
Intraoperative factors: the mean operative time was 295 min
(±55 min). The mean blood loss was 450 ml (range 250e700 ml)
and the median blood transfusion was 1 (range 0e3) units. In this
study we considered only resectable cancer so we did not per-
formed vascular resection. 18 patients went to Intensive Care Unit
(ICU) in postoperative period.
Postoperative course: 12.1% of patients had an intra-abdominal
complication. The more frequent complication was DGE respon-
sable of increased length of hospital stay and readmission rate.
POPF of grade C with re-laparotomy occurred in 4 patients. 2 pa-
tients developed a postpancreatectomy hemorrhage. In the ﬁrst
case we noted “digested blood” from the abdominal drain in 6
POD. In the second case we observed hematemesis and melena in
12 POD. In all 6 cases underwent to re-operation the patients were
transferred to ICU. Perioperative mortality was 4.1%. The mean
postoperative hospital stay was 21 days (range 11e48).
Pathology: All patients had a malignant etiology. In this study
the most common pathology was ductal adenocarcinoma of the
head of pancreas (78 cases). We also described ampullary and
duodenal cancer (11 cases), distal bile duct cancer (6 cases) and
neuroendocrine pancreatic tumor (2 cases). The lymph nodes were
involved by the tumor in 38.5% of cases.
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An Italian surgeon, Alessandro Codivilla, was the ﬁrst to perform
a pancreaticoduodenectomy. Than Allen O Whipple modiﬁed this
procedure in 1935, but the complexity of technique and the asso-
ciated high morbidity and mortality resulted in initial reluctance to
adopt this surgery for the management of pancreatic and peri-
ampullary tumors [19]. In the United States surgical resection is
underutilized for patients with pancreatic cancer: only 27e35% of
patients with locoregional disease are resected and this percentage
is until lower in elderly patients [20]. Several studies suggest that,
despite the increased morbidity and mortality after pancreatic
resection in this group, the survival beneﬁt of surgical resection for
pancreatic cancer is not diminished with age [21]. In our study we
treated patients over 70 years old that needing for a recovery in
Intensive Care Unit (ICU) in postoperative period with increased
risk to develop cardiac and respiratory complications. It is well
documented that the surgical outcome of pancreatic surgery are
better at high-volume experienced center that reporting mortality
rates below 5% [22]. During the past 5 years of our experience in
Whipple procedure we developed a progressive improvement in
the different aspects of the surgical technique including less
intraoperative bleeding, less pancreatic anastomosis failure and
decrease in hospital staying days. We perform an end-to-side duct-
to-mucosa pancreaticojejunostomy with routinely use of internal
pancreatic stent. This modiﬁed technique leads us to decrease
pancreatic leaks and ﬁstula with the rationale that stenting pre-
vents the accumulation of pancreatic secretions, so the pan-
creaticojejunostomy is excluded from direct contact with
pancreatic juice [14]. Several studies examined the efﬁcacy of in-
ternal and external pancreatic stents in preventing POPF but the
results are still in contrast [23,24]. POPF is the most important
complication of pancreaticoduodenectomy because, directly or
indirectly, contributes to the other morbidity including DGE,
postpancreatectomy hemorrhage and death. The number of this
surgical procedure is increased in our center during the recent
years. Several studies have reported the effect of high-volume
center on the surgical and clinical outcome of patients with
reduction of perioperative morbidity and mortality.
5. Conclusion
Pancreatic cancer is the fourth cause of death for neoplasm in
industrialized countries. A radical pancreaticoduodenectomy is the
only chance, but this procedure has signiﬁcant mortality and
morbidity even in high volume centers. There are some factors for
predicting the prognosis, such as size of the tumor, degree of dif-
ferentiation, status of lymph nodes and the involvement of the
resected margins. The most important postoperative complication
is POPF that is responsable of other surgical and medical compli-
cations. For these reasons multiple techniques in anastomosing the
pancreatic duct to gastrointestinal (pancreaticojejunostomy) have
been described in literature. In this study we used end-to-side
duct-to-mucosa anastomosis or Blumgart technique with internal
pancreatic stent. However no one technique has been shown to
deﬁnitively be the solution to the problem. At our center we have a
reasonable volume and our data are comparable to literature.
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